This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Oncology  • Colon Cancer  • Alert me on articles by topic  Social Bookmarking   What's this?

Dennis J. Ahnen, MD; Tim Byers, MD, MPH

JAMA. 1998;280:1095-1096.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The use of surrogate end points in trials of colonic cancer chemoprevention has great appeal. Potential agents could be tested more quickly using far fewer patients than would be needed for trials using the development of colonic cancer or adenomas as end points. In this issue of THE JOURNAL, Holt and colleagues¹ report that increased dietary intake of low-fat dairy foods can alter putative intermediate biomarkers of colonic cancer risk. This study raises 2 important questions about the use of surrogate end points for colonic cancer: (1) are there any surrogate end points, short of adenoma formation, that reliably reflect colonic cancer risk and (2) is there currently a defined role for surrogate end point studies in decision making about which agents to test in colonic cancer chemoprevention trials? The answer to both of these questions probably is no.

An ideal surrogate . . . [Full Text of this Article]

From the University of Colorado School of Medicine (Drs Ahnen and Byers) and the Denver Department of Veterans Affairs Medical Center (Dr Ahnen), Denver, Colo.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Calcium Intake and Colon Cancer Biomarkers
Peter R. Holt, Martin Lipkin, Harold Newmark, Dennis J. Ahnen, and Tim Byers
JAMA. 1999;281(13):1172.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Modulation of Abnormal Colonic Epithelial Cell Proliferation and Differentiation by Low-Fat Dairy Foods: A Randomized Controlled Trial
Peter R. Holt, Evren O. Atillasoy, Jody Gilman, Janet Guss, Steven F. Moss, Harold Newmark, Kunhua Fan, Kan Yang, and Martin Lipkin
JAMA. 1998;280(12):1074-1079.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased microvascular blood content is an early event in colon carcinogenesis
Wali et al.
Gut 2005;54:654-660.
ABSTRACT | FULL TEXT  

Down-regulation of SNAIL suppresses MIN mouse tumorigenesis: Modulation of apoptosis, proliferation, and fractal dimension
Roy et al.
Molecular Cancer Therapeutics 2004;3:1159-1165.
ABSTRACT | FULL TEXT  

Colonic Epithelial Cell Proliferation Decreases with Increasing Levels of Serum 25-Hydroxy Vitamin D
Holt et al.
Cancer Epidemiol. Biomarkers Prev. 2002;11:113-119.
ABSTRACT | FULL TEXT  

Red meat and colon cancer: dietary haem-induced colonic cytotoxicity and epithelial hyperproliferation are inhibited by calcium
Sesink et al.
Carcinogenesis 2001;22:1653-1659.
ABSTRACT | FULL TEXT  

Soy, soy phytoestrogens (isoflavones), and breast cancer
Messina
Am. J. Clin. Nutr. 1999;70:574-575.
FULL TEXT  

Calcium Intake and Colon Cancer Biomarkers
Holt et al.
JAMA 1999;281:1172-1172.
FULL TEXT